查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1661279

2025 年至 2033 年人造器官市场规模、份额、趋势及预测（按类型和地区）

Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球人工器官市场规模达到 222 亿美元。北美目前占据市场主导地位，到 2024 年的市场份额将超过 45.0%。

与传统的金属、矿物和合成材料相比，生物材料具有高导电性、强度、生物相容性和生物降解性。因此，先进生物材料在人工器官中的应用不断增加，目前是推动市场成长的主要驱动力之一。除此之外，生物材料在医疗器材、组织工程、药物和基因传递、微创手术（MIS）和生物感测器领域的应用也在增加。除此之外，由于全球范围内器官衰竭和疾病的数量不断增加，对人工器官中生物材料的需求也不断增长，这对市场产生了积极影响。

报告涵盖了市场结构、主要参与者的市场份额、参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。市场结构本质上是分散的，有大量国际和地区参与者参与该行业。由于产品差异化和转换成本较低，人工器官产业的新进入者数量适中。然而，严格的政府政策法规和高昂的投资成本阻碍了新进业者进入人工器官市场。

什么是人造器官？

人工器官是经过特殊设计的装置，可以植入人体来取代原来的器官。它们是透过从移植接受者身上获得的各种材料製造的，例如金属、无生命聚合物、活细胞和接种干细胞的塑胶。它们被广泛用作肾臟、肺、肝、心臟、人工胰腺和人工耳蜗。它们非常适合人体，因为人体的免疫系统不会排斥人工器官。它们不需要持续依赖电源或任何其他固定资源来维持严重器官衰竭患者的生命。它们协助提供与健康器官类似的功能或执行特定的功能。他们还协助提供生命维持，以防止在等待移植期间濒临死亡。除此之外，它还有利于透过美容修復、癌症手术后或事故改善患者的生活。由于它们能够挽救人们的生命并协助人们进行活动，因此全球对人工器官的需求正在上升。

COVID-19 影响：

新冠肺炎疫情爆发，为各行各业带来严峻考验，也为各国带来前所未有的挑战。由于人工器官是必需品，因此其产业并未受到疫情的严重阻碍。该行业的生产设施或单位并未关闭。不过，由于原料产业供应链中断，疫情初期人工器官的生产受到了影响。同时，由于担心病毒广泛传播，劳动力短缺，这在新冠疫情爆发的最初几个月影响了人工器官市场。此外，各国管理机构对道路运输都制定了严格的规章制度，阻碍了物流和运输业的发展。这在短期内对人工器官产业的供应链造成了暂时影响。此外，全球移植治疗和诊断率较低，迫使主要参与者降低生产能力，并在疫情期间面临相当大的经济损失。此外，由于世界各地对商品和服务进出口等贸易活动的跨境限制和禁令，对人造器官的需求有所下降。此外，与在体内植入人工器官相比，人们更关注与冠状病毒相关的治疗方案。然而，在重新开放封锁措施后，预计未来几年对人造器官的需求将会增加。

人工器官市场趋势：

目前，由于全球器官捐赠者数量减少，对人工器官的需求增加是积极影响市场的主要因素之一。此外，由于全球范围内器官衰竭和残疾人数不断增加，人工器官的采用也不断增加，这也促进了市场的成长。除此之外，穿戴式科技、微晶片技术和非侵入性诊断技术等医疗设备的各种技术进步都为市场带来了积极的前景。除此之外，先进生物材料在人工器官中的应用越来越多，以提供高强度、导电性和生物相容性，为产业投资者提供了丰厚的成长机会。此外，世界各地对于非常适合改善人们生活的人造器官的需求也不断增加。再加上由于生活习惯和生活方式的改变，大众患上生活方式相关疾病的数量不断增加，推动了市场的成长。与此相符的是，人们越来越倾向于使用精确诊断方法来监测人工器官，这推动了市场的成长。此外，主要参与者正在将人工智慧（AI）和嵌入式感测器引入人工器官，从而增强市场的成长。

本报告解答的关键问题

  • 什么是人造器官？人造器官市场有多大？
  • 2025-2033年全球人工器官市场的预期成长率是多少？
  • 推动全球人工器官市场发展的关键因素有哪些？
  • 根据类型，全球人工器官市场的主要细分市场是什么？
  • 全球人工器官市场的主要区域有哪些？
  • 全球人工器官市场的关键参与者/公司有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第五章：全球人工器官市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场区隔：按类型
  • 市场分布：按地区
  • 市场预测
  • SWOT 分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
    • 概述
    • 研究与开发
    • 原物料采购
    • 製造业
    • 行销
    • 分配
    • 最终用途
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁

第六章：市场细分：依类型

  • 人工肾臟
    • 市场趋势
    • 市场预测
  • 人工心臟
    • 市场趋势
    • 市场预测
  • 人工胰臟
    • 市场趋势
    • 市场预测
  • 人工耳蜗
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第七章：市场区隔：依地区

  • 北美洲
    • 市场趋势
    • 市场预测
  • 欧洲
    • 市场趋势
    • 市场预测
  • 亚太地区
    • 市场趋势
    • 市场预测
  • 中东和非洲
    • 市场趋势
    • 市场预测
  • 拉丁美洲
    • 市场趋势
    • 市场预测

第 8 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abiomed, Inc.
    • HeartWare International, Inc.
    • Edwards Lifesciences Corp
    • Boston Scientific Corporation
    • Cochlear Limited
Product Code: SR112025A833

The global artificial organs market size reached USD 22.2 Billion in 2024. Looking forward, the IMARC Group expects the market to reach USD 44.5 Billion by 2033, exhibiting a growth rate CAGR of 7.22% during 2025-2033. North America currently dominates the market, holding a market share of over 45.0% in 2024. The increasing need for 3D bioprinting due to its capability to minimize the risk of organ rejection, rising prevalence of chronic diseases, such as cancer, diabetes, hypertension, stroke, heart disease, and respiratory diseases, and escalating demand for organ transplantation.

Biomaterials offer high conductivity, strength, bio-compatibility, and bio-degradability as compared to conventional metal, mineral, and synthetic-based materials. As a result, there is a rise in the adoption of advanced biomaterials in artificial organs, which currently represents one of the primary drivers contributing to the growth of the market. In addition to this, there is an increase in the utilization of biomaterials in medical devices, tissue engineering, drug and gene delivery, minimally invasive surgery (MIS), and biosensors. Apart from this, the growing demand for biomaterials in artificial organs due to the increasing number of organ failures and diseases among individuals across the globe is positively influencing the market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is fragmented in nature with a large number of international and regional players operating in the industry. The volume of new entrants is moderate in the artificial organs industry on account of the low product differentiation and switching costs. However, stringent government policies and regulations and high investment costs hinder the entry of new entrants in the artificial organ market.

What are Artificial Organs?

Artificial organs are engineered devices designed to be implanted in a human body as an alternative to the original organ. They are manufactured through various materials, such as metals, inanimate polymers, living cells, and plastic seeded with stem cells, that are obtained from the transplant recipient. They are widely available as kidney, lung, liver, heart, and artificial pancreas, and cochlear implants. They are highly suitable for the body as the immune system of the body does not reject the artificial organ. They do not require continuous tethering to a power supply or any other stationary resource to keep patients with serious organ failure. They assist in providing similar functions of a healthy organ or performing a specific function. They also aid in offering life support to prevent imminent death while waiting for a transplant. Besides this, it is beneficial in improving the life of a patient through cosmetic restoration, post-cancer surgery or an accident. As they save the life of individuals and aid in performing activities, the demand for artificial organs is rising across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak has caused severe problems for numerous industries and imposed unprecedented challenges on various countries. The artificial organ industry was not severely hampered by the pandemic as these are essential products. The production facilities or units of the industry were not shut down. Although, the manufacturing of artificial organs has been affected in the initial period of the pandemic on account of the supply chain disruptions from the raw materials industry. In line with this, there was a shortage of labor due to the fear of the widespread virus, which impacted the artificial organs market in the starting months of the COVID-19 pandemic. Apart from this, governing agencies of various countries have imposed stringent rules and regulations on on-road movement, which hampered the logistical and transportation industry. This has temporarily impacted the supply chain in the short term for the artificial organs industry. Moreover, there was a lower rate of transplant treatment and diagnostic across the globe that forced key players to descale their production capacity, and they faced some considerable financial losses during the pandemic. Besides this, there was a declined demand for artificial organs on account of the cross-border restrictions and bans on trade activities, such as imports and exports of goods and services around the world. Additionally, people were more focused on the treatment options related to the coronavirus as compared to implanting artificial organs in the body. However, after the reopening of lockdown measures, the demand for artificial organs is expected to increase in the coming years.

Artificial Organs Market Trends:

At present, the increasing demand for artificial organs due to the decreasing number of organ donors around the world represents one of the major factors influencing the market positively. Additionally, the rising adoption of artificial organs due to the increasing number of organ failures and disabilities among individuals across the globe is contributing to the growth of the market. Apart from this, various technological advancements in medical devices, such as wearable technology, microchips technology, and non-invasive diagnostic techniques, are offering a positive market outlook. In addition to this, the increasing utilization of advanced biomaterials in artificial organs to provide high strength, conductivity, and bio-compatibility is offering lucrative growth opportunities to industry investors. Moreover, there is a rise in demand for artificial organs that are highly suitable to enhance the lives of individuals around the world. This, coupled with the growing number of lifestyle-related diseases among the masses due to the changing habits and lifestyles, is bolstering the growth of the market. In line with this, the rising preference for monitoring artificial organs by using precise diagnostics is impelling the growth of the market. Furthermore, key players are introducing artificial intelligence (AI) and embedded sensors in artificial organs, which is strengthening the growth of the market.

Key Market Segmentation:

Type Insights:

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for artificial organs. Some of the factors driving the North America artificial organs market included the growing prevalence of organ failures and disabilities among the masses, rising adoption for the treatment of several cancers, and increasing number of diseases and low availability of organ donors. In addition to this, key players operating in the region are introducing miniature heart pump devices that provide smart patient management for enhanced patient experience, which is contributing to the growth of the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global artificial organs market. Some of the companies covered in the report include:

  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited
  • Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.What are artificial organs?
  • 2.How big is the artificial organs market?
  • 3.What is the expected growth rate of the global artificial organs market during 2025-2033?
  • 4.What are the key factors driving the global artificial organs market?
  • 5.What is the leading segment of the global artificial organs market based on the type?
  • 6.What are the key regions in the global artificial organs market?
  • 7.Who are the key players/companies in the global artificial organs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Organs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Region
  • 5.6 Market Forecast
  • 5.7 SWOT Analysis
    • 5.7.1 Overview
    • 5.7.2 Strengths
    • 5.7.3 Weaknesses
    • 5.7.4 Opportunities
    • 5.7.5 Threats
  • 5.8 Value Chain Analysis
    • 5.8.1 Overview
    • 5.8.2 Research and Development
    • 5.8.3 Raw Material Procurement
    • 5.8.4 Manufacturing
    • 5.8.5 Marketing
    • 5.8.6 Distribution
    • 5.8.7 End-Use
  • 5.9 Porters Five Forces Analysis
    • 5.9.1 Overview
    • 5.9.2 Bargaining Power of Buyers
    • 5.9.3 Bargaining Power of Suppliers
    • 5.9.4 Degree of Competition
    • 5.9.5 Threat of New Entrants
    • 5.9.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Artificial Kidney
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Artificial Heart
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Artificial Pancreas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cochlear Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Europe
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Asia Pacific
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Middle East and Africa
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Latin America
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Competitive Landscape

  • 8.1 Market Structure
  • 8.2 Key Players
  • 8.3 Profiles of Key Players
    • 8.3.1 Abiomed, Inc.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Description
      • 8.3.1.3 Product Portfolio
      • 8.3.1.4 Financials
      • 8.3.1.5 SWOT Analysis
    • 8.3.2 HeartWare International, Inc.
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Description
      • 8.3.2.3 Product Portfolio
      • 8.3.2.4 Financials
      • 8.3.2.5 SWOT Analysis
    • 8.3.3 Edwards Lifesciences Corp
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Description
      • 8.3.3.3 Product Portfolio
      • 8.3.3.4 Financials
      • 8.3.3.5 SWOT Analysis
    • 8.3.4 Boston Scientific Corporation
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Description
      • 8.3.4.3 Product Portfolio
      • 8.3.4.4 Financials
      • 8.3.4.5 SWOT Analysis
    • 8.3.5 Cochlear Limited
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Description
      • 8.3.5.3 Product Portfolio
      • 8.3.5.4 Financials
      • 8.3.5.5 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Organs Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Organs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Organs Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Artificial Organs Market: Breakup by Region (in %), 2024
  • Figure 5: Global: Artificial Organs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 6: Global: Artificial Organs Industry: SWOT Analysis
  • Figure 7: Global: Artificial Organs Industry: Value Chain Analysis
  • Figure 8: Global: Artificial Organs Industry: Porter's Five Forces Analysis
  • Figure 9: Global: Artificial Organs (Artificial Kidney) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Artificial Organs (Artificial Kidney) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Artificial Organs (Artificial Heart) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Artificial Organs (Artificial Heart) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Artificial Organs (Artificial Pancreas) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Artificial Organs (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Artificial Organs (Cochlear Implants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Artificial Organs (Cochlear Implants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Artificial Organs (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Artificial Organs (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Europe: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Europe: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Asia Pacific: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Asia Pacific: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Middle East and Africa: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Middle East and Africa: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Latin America: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Latin America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Artificial Organs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Organs Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Organs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 4: Global: Artificial Organs Market Structure
  • Table 5: Global: Artificial Organs Market: Key Players